Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live … – Business Wire (press release)
|
Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live …
Business Wire (press release) “Dr. Honda's research suggests an entirely new approach to cancer immunotherapy harnessing the human microbiome, which has the potential to significantly enhance the effectiveness of cancer therapies,” said Bernat Olle, PhD, Chief Executive Officer of … |
